AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-91384919/us-health-authorities-approve.html" title="Facts and information about US health authorities approve Elan drug applications.(Brief Article)">US health authorities approve Elan drug applications.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
US health authorities approve Elan drug applications.(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
Irish pharmaceutical company Elan Corp Plc has received approval from the US Food and Drug Administration (FDA) for new versions of its Skelaxin and Zanaflex drugs.
The FDA approved a supplemental new drug application (sNDA) for an 800mg strength Skelaxin (metaxalone) tablet and a new drug application (NDA) for a capsule form of Elan's Zanaflex (tizanidine hydrochloride) drug in 2mg, 4mg and 6mg doses. …
Related articles from newspapers, magazines, journals, and more
-
- Elan Corp plc: Elan and Biogen Idec announce initiation of Antegren...
-
News wire article from: Asia Africa Intelligence Wire
February 3, 2004
700+ words
-
- Elan Corp plc announces pharma marketing lawsuit.
-
News wire article from: Asia Africa Intelligence Wire
January 17, 2003
700+ words
-
- Elan Corp plc UK Regulatory announcement: Elan announces agreement with...
-
News wire article from: Asia Africa Intelligence Wire
March 30, 2004
700+ words
-
- Johnson & Johnson and Elan Corp plc announce definitive agreement for...
-
News wire article from: Chemical Business Newsbase
July 2, 2009
700+ words
-
- Johnson & Johnson and Elan Corp plc announce closing of transaction...
-
News wire article from: Chemical Business Newsbase
September 17, 2009
700+ words
